DrugPatentWatch Database Preview
Details for Patent: 8,513,299
Which drugs does patent 8,513,299 protect, and when does it expire?
This patent has ten patent family members in four countries.
Summary for Patent: 8,513,299
Title: | Methods of using low-dose doxepin for the improvement of sleep |
Abstract: | Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg). |
Inventor(s): | Rogowski; Roberta L. (Rancho Santa Fe, CA), Dube; Susan E. (Carlsbad, CA), Jochelson; Philip (San Diego, CA) |
Assignee: | Pernix Sleep, Inc. (The Woodlands, TX) Procom One, Inc. (San Marcos, TX) |
Application Number: | 11/804,720 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,513,299
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET;ORAL | 022036-001 | Mar 17, 2010 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | TREATMENT OF INSOMNIA | ➤ Try a Free Trial | ||||
Pernix Theraps Llc | SILENOR | doxepin hydrochloride | TABLET;ORAL | 022036-002 | Mar 17, 2010 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | TREATMENT OF INSOMNIA | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,513,299
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
9,486,437 | Methods of using low-dose doxepin for the improvement of sleep | ➤ Try a Free Trial |
9,498,462 | Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders | ➤ Try a Free Trial |
9,801,847 | Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders | ➤ Try a Free Trial |
9,107,898 | Methods of using low-dose doxepin for the improvement of sleep | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,513,299
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2687118 | ➤ Try a Free Trial | |||
Canada | 2687124 | ➤ Try a Free Trial | |||
European Patent Office | 2026792 | ➤ Try a Free Trial | |||
Japan | 2009537553 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |